LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 21.18%24.72B | 11.91%19.37B | 37.49%19.25B | 40.89%71.11B | 33.72%19.4B | 110.50%20.4B | 41.92%17.31B | -0.55%14B | -12.50%50.48B | -19.85%14.51B |
Net income from continuing operations | 35.44%15.69B | 72.87%13.47B | 116.66%12.37B | 68.53%39.1B | 201.25%14.02B | 163.55%11.58B | 16.48%7.79B | -23.52%5.71B | -41.07%23.2B | -54.76%4.65B |
Depreciation and amortization | 40.85%4.03B | 38.66%3.64B | 33.68%3.37B | 28.69%11.18B | 33.50%3.17B | 31.45%2.86B | 32.54%2.62B | 17.07%2.52B | 9.02%8.69B | 17.97%2.38B |
Deferred tax | -142.90%-1.31B | -44.42%-1.64B | 26.45%-456M | 103.99%131M | 1.02%-1.16B | 377.94%3.05B | -150.99%-1.14B | -10.12%-620M | -639.57%-3.29B | -256.82%-1.17B |
Other non cash items | -114.86%-11M | -102.37%-5M | -842.86%-66M | -79.26%411M | -93.04%133M | -28.85%74M | 12.23%211M | 96.83%-7M | 1,660.63%1.98B | 5,520.59%1.91B |
Change In working capital | 308.04%2.07B | -120.99%-741M | -91.33%223M | -32.50%3.84B | -165.82%-1.27B | -275.18%-995M | 697.07%3.53B | -6.20%2.57B | 711.86%5.68B | -26.19%1.93B |
-Change in receivables | 121.09%143M | 17.84%-1.17B | -1.02%2.52B | -1,138.53%-2.4B | -67.33%-2.84B | -545.71%-678M | -172.80%-1.42B | -0.43%2.55B | 107.43%231M | 16.63%-1.7B |
-Change in prepaid assets | 79.74%-184M | -55.56%-84M | -87.82%100M | 245.06%559M | -18.13%700M | -9.27%-908M | 87.59%-54M | 43.28%821M | 109.26%162M | 4.78%855M |
-Change in payables and accrued expense | 77.25%1.24B | -104.82%-247M | -136.24%-2.39B | 13.79%5.13B | -85.75%320M | -30.03%699M | 244.06%5.12B | -350.89%-1.01B | -9.22%4.51B | -38.90%2.25B |
-Change in other current assets | 19.44%-29M | 43.24%53M | -413.33%-94M | 24.53%-80M | -305.56%-111M | -28.57%-36M | 254.17%37M | 127.78%30M | 69.63%-106M | 132.73%54M |
-Change in other current liabilities | 1,351.39%901M | 568.21%707M | -54.89%83M | -29.57%624M | 39.58%663M | -113.51%-72M | -132.31%-151M | 422.81%184M | -5.84%886M | 14.73%475M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 21.18%24.72B | 11.91%19.37B | 37.49%19.25B | 40.89%71.11B | 33.72%19.4B | 110.50%20.4B | 41.92%17.31B | -0.55%14B | -12.50%50.48B | -19.85%14.51B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -41.85%-8.62B | -59.48%-8.3B | -29.53%-8.73B | 15.45%-24.5B | 14.06%-6.47B | 37.36%-6.08B | 25.23%-5.2B | -41.10%-6.74B | -282.69%-28.97B | -229.20%-7.53B |
Net PPE purchase and sale | -27.12%-8.26B | -33.24%-8.17B | 6.20%-6.4B | 13.28%-27.05B | 15.53%-7.59B | 30.56%-6.5B | 18.52%-6.13B | -28.37%-6.82B | -67.96%-31.19B | -67.41%-8.99B |
Net business purchase and sale | -247.37%-132M | 31.33%-57M | 83.78%-72M | 52.06%-629M | -3.23%-64M | -11.76%-38M | 77.13%-83M | 47.95%-444M | -54.17%-1.31B | 88.10%-62M |
Net investment purchase and sale | -175.80%-354M | -105.10%-56M | -603.79%-2.26B | -9.34%3.2B | -22.01%1.19B | 242.38%467M | 17.04%1.1B | -67.91%449M | -71.00%3.53B | -87.15%1.52B |
Net other investing changes | 1,340.00%124M | ---- | ---- | -475.00%-23M | 0.00%-3M | -162.50%-10M | -1,114.29%-85M | 850.00%75M | 98.79%-4M | 97.60%-3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -41.85%-8.62B | -59.48%-8.3B | -29.53%-8.73B | 15.45%-24.5B | 14.06%-6.47B | 37.36%-6.08B | 25.23%-5.2B | -41.10%-6.74B | -282.69%-28.97B | -229.20%-7.53B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 25.60%-4.37B | -311.22%-11.18B | -87.97%-19.77B | 11.91%-19.5B | -18.99%-8.4B | -373.64%-5.88B | 180.63%5.29B | 1.35%-10.52B | 56.36%-22.14B | 67.53%-7.06B |
Net issuance payments of debt | 3,653.56%9.49B | -103.63%-299M | -19.32%-315M | -18.45%7.4B | -30.64%-307M | -102.74%-267M | 3,860.27%8.24B | -13.30%-264M | 1,439.88%9.07B | -25.67%-235M |
Net common stock issuance | -147.07%-8.82B | -601.45%-6.3B | -60.26%-15.01B | 29.27%-19.77B | 13.42%-5.94B | 43.83%-3.57B | 82.84%-898M | 1.48%-9.37B | 37.23%-27.96B | 65.79%-6.86B |
Cash dividends paid | ---1.26B | ---1.27B | ---1.27B | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | -85.29%-3.78B | -62.05%-3.31B | -257.50%-3.17B | -119.10%-7.12B | -5,763.16%-2.15B | -62.21%-2.04B | -84.07%-2.05B | 3.69%-887M | 41.04%-3.25B | 102.54%38M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 25.60%-4.37B | -311.22%-11.18B | -87.97%-19.77B | 11.91%-19.5B | -18.99%-8.4B | -373.64%-5.88B | 180.63%5.29B | 1.35%-10.52B | 56.36%-22.14B | 67.53%-7.06B |
Net cash flow | ||||||||||
Beginning cash position | 10.81%33.03B | 167.99%33.28B | 174.60%42.83B | -7.52%15.6B | 148.51%37.9B | 121.13%29.8B | -19.10%12.42B | -7.52%15.6B | -6.07%16.87B | 3.02%15.25B |
Current changes in cash | 38.85%11.73B | -100.61%-106M | -183.81%-9.26B | 4,397.62%27.12B | 5,763.75%4.53B | 295.23%8.45B | 1,412.07%17.4B | -139.25%-3.26B | -2.60%-631M | -103.65%-80M |
Effect of exchange rate changes | 203.95%368M | -985.71%-152M | -438.82%-288M | 117.71%113M | -6.82%396M | 3.01%-354M | 97.45%-14M | 157.05%85M | -34.60%-638M | 426.92%425M |
End cash Position | 19.07%45.13B | 10.81%33.03B | 167.99%33.28B | 174.60%42.83B | 174.60%42.83B | 148.51%37.9B | 121.13%29.8B | -19.10%12.42B | -7.52%15.6B | -7.52%15.6B |
Free cash flow | 18.41%16.47B | 0.20%11.2B | 79.04%12.85B | 130.24%43.85B | 111.98%11.59B | 4,286.75%13.91B | 141.67%11.18B | -16.91%7.18B | -51.16%19.04B | -56.96%5.47B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |